Clinical trial

Tezosentan in Acute Heart Failure

NCT00525707

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-04-01

PhasePHASE3

Study timeline

Study start (unknown)2003-04-01Date precision: month

Registry last updated2018-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Heart Failureunresolved

Acute Decompensation of Chronic Heart Failureunresolved

New Onset of Heart Failureunresolved

Interventions

tezosentanDRUG

Sponsors & collaborators

Idorsia Pharmaceuticals Ltd.lead sponsor

Mapped research locations

KrakowPoland2 HoustonTexas, United States1 PittsburghPennsylvania, United States1 BirminghamAlabama, United States1 BerlinGermany1 DenverColorado, United States1 ToulouseFrance1 StrasbourgFrance1 ViennaAustria1 AthensGreece1 Palo AltoCalifornia, United States1 HaifaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00525707 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.